ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
arnies
|
79 |
36K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
36K
|
1
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
arnies
|
1.5K |
792K |
6 |
28/02/24 |
28/02/24 |
Charts
|
1.5K
|
792K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
arnies
|
400 |
169K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
400
|
169K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
arnies
|
314 |
154K |
1 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
314
|
154K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
arnies
|
314 |
154K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
314
|
154K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
arnies
|
314 |
154K |
0 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
314
|
154K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
arnies
|
314 |
154K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
314
|
154K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
arnies
|
314 |
154K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
314
|
154K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2023 quarterly activity report
|
|
arnies
|
24 |
10K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
24
|
10K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
arnies
|
166 |
75K |
6 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Take Over Opportunity
|
|
arnies
|
42 |
19K |
17 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
42
|
19K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
arnies
|
208 |
84K |
3 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
84K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
arnies
|
208 |
84K |
0 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
84K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
arnies
|
208 |
84K |
5 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
84K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
arnies
|
208 |
84K |
3 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
84K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
arnies
|
208 |
84K |
9 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
84K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 18 December 2023
|
|
arnies
|
11 |
6.5K |
25 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
11
|
6.5K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 18 December 2023
|
|
arnies
|
11 |
6.5K |
58 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
11
|
6.5K
|
58
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
arnies
|
208 |
84K |
15 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
84K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Hair Loss was
|
|
arnies
|
6 |
2.4K |
15 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
6
|
2.4K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
arnies
|
315 |
154K |
0 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
154K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
arnies
|
315 |
154K |
9 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
154K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
arnies
|
315 |
154K |
14 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
154K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
the game is ON
|
|
arnies
|
123 |
61K |
2 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
123
|
61K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
arnies
|
9.6K |
4.3M |
3 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine Trial and Forward Plans
|
|
arnies
|
29 |
9.0K |
3 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
29
|
9.0K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
arnies
|
677 |
319K |
5 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
677
|
319K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Daybue Feedback
|
|
arnies
|
47 |
22K |
0 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
47
|
22K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
arnies
|
90 |
33K |
3 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
90
|
33K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
arnies
|
9.6K |
4.3M |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine Phase 2 Study
|
|
arnies
|
8 |
1.9K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
8
|
1.9K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren and Acadia expand global partnership for trofinetide
|
|
arnies
|
153 |
66K |
10 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
153
|
66K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
arnies
|
9.6K |
4.3M |
4 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
9.6K
|
4.3M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Change of Director's Interest Notice
|
|
arnies
|
35 |
14K |
20 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
35
|
14K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Neuren AGM 30th May
|
|
arnies
|
81 |
34K |
2 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
81
|
34K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren AGM 30th May
|
|
arnies
|
81 |
34K |
12 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
81
|
34K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren AGM 30th May
|
|
arnies
|
81 |
34K |
9 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
81
|
34K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Neuren AGM 30th May
|
|
arnies
|
81 |
34K |
6 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
81
|
34K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Neuren AGM 30th May
|
|
arnies
|
81 |
34K |
3 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
81
|
34K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren AGM 30th May
|
|
arnies
|
81 |
34K |
6 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
81
|
34K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
ROW - Nearest to pin
|
|
arnies
|
16 |
9.0K |
4 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
16
|
9.0K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
ROW Rights
|
|
arnies
|
67 |
33K |
0 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
67
|
33K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Wilsons target $18.29 and summary
|
|
arnies
|
65 |
35K |
2 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
65
|
35K
|
2
|
|
ASX - By Stock
|
PCL |
Re:
Ann: Namibia PEL 87 Project Update
|
|
arnies
|
60 |
32K |
15 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
60
|
32K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Distrubutions to New Zealand shareholders
|
|
arnies
|
4 |
3.2K |
4 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
4
|
3.2K
|
4
|
|
ASX - By Stock
|
NEU |
Trof sales
|
|
arnies
|
10 |
3.9K |
59 |
15/04/23 |
15/04/23 |
ASX - By Stock
|
10
|
3.9K
|
59
|
|
ASX - By Stock
|
TON |
Re:
Ann: Ancuabe graphite project update
|
|
arnies
|
42 |
23K |
2 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
42
|
23K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Ann: FDA Clears iTrack Advance for US Launch
|
|
arnies
|
45 |
13K |
1 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
45
|
13K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: FDA Clears iTrack Advance for US Launch
|
|
arnies
|
45 |
13K |
5 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
45
|
13K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Shorting the sucker-rally
|
|
arnies
|
342 |
116K |
14 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
342
|
116K
|
14
|
|